How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Pharma and Healthcare · Forecast 2027–2033
Oxygen Therapy Equipments Market
- By Product Type: Oxygen Concentrators, Oxygen Cylinders, Liquid Oxygen Systems, Oxygen Generators, Oxygen Masks and Cannulas
- By Mode of Delivery: Continuous Flow Oxygen Therapy, Pulse Dose Oxygen Therapy, Intermittent Oxygen Therapy
- By End User: Hospitals, Home Healthcare Settings, Ambulatory Care Centers, Long-term Care Facilities
- By Application: Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Asthma, Sleep Apnea, Cystic Fibrosis
- By Technology: Portable Oxygen Concentrators, Stationary Oxygen Concentrators, Compressed Gas Technology, Cryogenic Liquid Technology
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Projected to reach $X,XXX.XM by 2033 on sustained demand. Market Outlook →
- 03 Growth - X.XX% CAGR across 2027–2033, with the full year-by-year model inside. Market Outlook →
- 04 Leading segment - Oxygen Concentrators leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Oxygen Therapy Equipments Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Mode of Delivery 3
End User 4
Application 5
Technology 4
Companies profiled
Philips Healthcare
ResMed Inc.
Invacare Corporation
Drive DeVilbiss Healthcare
Fisher & Paykel Healthcare
Air Liquide Healthcare
Linde Healthcare
Nidek Medical Products
Chart Industries (AirSep)
Hamilton Medical AG
DeVilbiss Healthcare
3B Medical Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →ResMed Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Invacare Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Drive DeVilbiss Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Fisher & Paykel Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Air Liquide Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Linde Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Nidek Medical Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Chart Industries (AirSep)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Hamilton Medical AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →DeVilbiss Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →3B Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Inogen Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →OxyGo
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Caire Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →
Global · 2025–2033
$5,792M by 2033 · 7.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Oxygen Concentrators45.9
- Oxygen Cylinders12.6
- Liquid Oxygen Systems10.7
- Oxygen Generators9.0
- Oxygen Masks and Cannulas21.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,114M → $1,782M · 6.0%
Europe$776.4M → $1,470M · 8.3%
Asia Pacific$708.9M → $1,302M · 7.9%
Latin America$438.9M → $748.9M · 6.9%
Middle East and Africa$337.6M → $537.1M · 6.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.942026
6.952027
6.962028
6.982029
6.992030
7.002031
7.002032
7.012033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Philips Healthcare19.7
- ResMed Inc.12.1
- Invacare Corporation6.4
- Drive DeVilbiss Healthcare17.3
- Fisher & Paykel Healthcare5.4
- Air Liquide Healthcare11.2
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type10.8%
Mode of Delivery12.0%
End User28.8%
Application30.0%
Technology18.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.5
- Europe25.2
- Asia Pacific22.3
- Latin America12.8
- Middle East and Africa9.2
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Philips Healthcare | 93 | 96 | 77 | 82 | 95 | 97 | 90 |
| ResMed Inc. | 69 | 72 | 87 | 75 | 91 | 76 | 78 |
| Invacare Corporation | 68 | 75 | 78 | 66 | 81 | 84 | 75 |
| Drive DeVilbiss Healthcare | 71 | 72 | 57 | 65 | 72 | 75 | 69 |
| Fisher & Paykel Healthcare | 55 | 52 | 55 | 66 | 71 | 54 | 59 |
| Air Liquide Healthcare | 57 | 66 | 49 | 50 | 60 | 63 | 58 |
| Linde Healthcare | 62 | 65 | 52 | 54 | 58 | 66 | 60 |
| Nidek Medical Products | 59 | 42 | 50 | 59 | 36 | 43 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Philips Healthcare
- ResMed Inc.
- Invacare Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Philips Healthcare | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| ResMed Inc. | ◐ | ✓ | ◐ | ◐ | ✓ | − |
| Invacare Corporation | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Drive DeVilbiss Healthcare | ✓ | ✓ | − | − | ◐ | ◐ |
| Fisher & Paykel Healthcare | − | − | ◐ | ◐ | ◐ | ◐ |
| Air Liquide Healthcare | − | ◐ | ◐ | − | − | − |
| Linde Healthcare | ◐ | ◐ | − | − | ◐ | ◐ |
| Nidek Medical Products | ◐ | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Philips Healthcare90
2ResMed Inc.78
3Invacare Corporation75
4Drive DeVilbiss Healthcare69
5Linde Healthcare60
6Fisher & Paykel Healthcare59
7Air Liquide Healthcare58
8Nidek Medical Products48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Philips HealthcareResMed Inc.
Challenger2
Strong scale, closing on the leaders.
Invacare CorporationDrive DeVilbiss Healthcare
Contender3
Focused players with pockets of strength.
Fisher & Paykel HealthcareAir Liquide HealthcareLinde Healthcare
Niche1
Specialists in a single segment or region.
Nidek Medical Products
Go-to-market strategy
Land Product Type in North America, then scale across Oxygen Therapy Equipments Market — a $408M beachhead inside a $6.25B market.
Beachhead (SOM)$408Mobtainable near-term
Serviceable (SAM)$2.24Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Oxygen Concentrators
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Oxygen Cylinders
Strong fit — clear ROI and a fast path to value.
End user70 fit
Liquid Oxygen Systems
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Mode of Delivery & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Oxygen Therapy Equipments Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified25%
Evaluation11%
Closed-won6%
$11.9KCAC
$57KLTV
4.8:1LTV : CAC
< 2 moCAC payback
Investment thesis
Oxygen Therapy Equipments Market is a durable-growth opportunity — $4.37B by 2033, compounding at 7.7%.
TAM · 2025$2.42Btoday
TAM · 2033$4.37Bforecast
CAGR7.7%2027–2033
Cumulative$29.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.37BTotal addressable market
SAM$1.78BServiceable available market
SOM$341MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.7% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.37BLarge & growingTAM by 2033 at 7.7% CAGR
$1.78BServiceable nowreachable with today’s model
$341MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.41BBear5.0% CAGR
$4.37BBase7.7% CAGR
$5.60BBull10.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Mode of Delivery optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Oxygen Therapy Equipments Market — a $5.19B market by 2033. Plan: grow share from 7.7% to 12.7%.
Market size · 2033$5.19Btotal addressable
Market CAGR3.9%2027–2033
Target share12.7%from 7.7% today
Revenue ambition$660Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.7% | 12.7% | On track |
| Revenue | $423M | $660M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.6% | 42.0% | Behind |
| Customer retention | 89.6% | 92.6% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Mode of Delivery capability
A defensible second engine — invest in Mode of Delivery to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Mode of Delivery
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $97M capacity & capability investment
- Greenlight bolt-on M&A in Mode of Delivery
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentAhead
Sales deck · value proposition
Win the Oxygen Therapy Equipments Market conversation — a $4.34B market you can size, segment and defend in minutes.
Market size · 2033$4.34Btotal opportunity
Growth6.3%CAGR to 2033
Addressable buyers995+accounts in scope
Typical ROI4.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.6×return on cost, year one
< 3 mopayback period
$64K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Philips HealthcareResMed Inc.Invacare CorporationDrive DeVilbiss HealthcareFisher & Paykel HealthcareAir Liquide HealthcareLinde HealthcareNidek Medical Products+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Oxygen Therapy Equipments Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Oxygen Therapy Equipments Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Pharma and Healthcare · scroll →Pill Organiser Market
Market size, share, segmentation and regional forecast.
$5.7B by 2032 · 5.38% CAGR
View reportClostridium Vaccine Market
Market size, share, segmentation and regional forecast.
$8.6B by 2031 · 10.05% CAGR
View reportTissue Forcep Market
Market size, share, segmentation and regional forecast.
$10.2B by 2033 · 4.72% CAGR
View reportAlumina Substrate for Chip Resistor Market
Market size, share, segmentation and regional forecast.
$5.3B by 2033 · 7.30% CAGR
View reportOtoscopes Market
Market size, share, segmentation and regional forecast.
$5.8B by 2033 · 4.46% CAGR
View reportRespiratory Drug Market
Market size, share, segmentation and regional forecast.
$795M by 2032 · 7.18% CAGR
View reportFucoxanthin Market
Market size, share, segmentation and regional forecast.
$7.8B by 2032 · 3.61% CAGR
View reportOrally Disintegrating Tablets Market
Market size, share, segmentation and regional forecast.
$3.6B by 2031 · 4.04% CAGR
View reportTuberculosis Drugs Market
Market size, share, segmentation and regional forecast.
$12.9B by 2032 · 8.73% CAGR
View reportOver-the-Counter Drug Market
Market size, share, segmentation and regional forecast.
$6.3B by 2032 · 8.68% CAGR
View reportAlpha Galactosidase A Market
Market size, share, segmentation and regional forecast.
$13.9B by 2032 · 8.22% CAGR
View reportTransdermal Drug Delivery Systems Market
Market size, share, segmentation and regional forecast.
$2.9B by 2032 · 4.78% CAGR
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.